Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/1999
10/28/1999CA2328430A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999CA2325848A1 B-cell growth factor related protein
10/28/1999CA2325805A1 Streptococcus preparation
10/28/1999CA2269103A1 Peptides binding to bone marrow stromal cell antigen
10/27/1999EP0952159A2 Use of somatostatin derivatives and/or of phenylhydrazone derivatives as antinflammatory or analgetic agents
10/27/1999EP0952149A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors
10/27/1999EP0952148A1 Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999EP0951467A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
10/27/1999EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999EP0951287A2 Oral composition comprising 5-aminosalicyclic acid
10/27/1999EP0951281A2 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR
10/27/1999EP0825856A4 Irritation relief using nonsteroidal anti-inflammatory compounds
10/27/1999CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999CN1233243A Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide
10/27/1999CN1233238A Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
10/27/1999CN1233237A Heteroaryl succinamides and their use as metalloproteinase inhibitors
10/27/1999CN1233177A Therapeutic treatment for VEGF related diseases
10/27/1999CN1233176A Substituted tricyclics
10/27/1999CN1233173A Therapeutic methods and compositions involving isoflavones
10/27/1999CN1233171A Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
10/27/1999CN1233169A Process for the manufacture of a pulverous preparation
10/27/1999CN1045964C Heterocyclic compounds and their preparation and use
10/27/1999CA2269995A1 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
10/26/1999US5973204 3-demethyl benzo(a)heptalene derivative used as antiinflammatory and muscle relaxant
10/26/1999US5973201 Phenylacetamide derivatives
10/26/1999US5973167 Sulfonamide group, ether containing acid
10/26/1999US5973111 Novel compounds that are capable of binding to the active site of interleukin-1b-converting enzyme (ice) and inhibiting activity of that enzyme; administering to treat inflammatory, autoimmune, and neurodegenerative diseases
10/26/1999US5972982 Containing 5-to 9-membered heteroaryl mono- or bicyclic ring system having no more than 1 carbonyl carbon in the ring system; viricides, bactericides
10/26/1999US5972972 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
10/26/1999US5972968 Interleukin inhibitor
10/26/1999US5972957 Analgesics and antiarthritic agent
10/26/1999US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999US5972936 Benzofuran carboxamides and their therapeutic use
10/26/1999US5972928 Administering an antigrowth agent
10/26/1999US5972927 Antiinflammatory, antiallergic and bronchodilatory medicinal products, treatment of asthma
10/26/1999US5972925 1-(3-(2-chloro-12h-dibenzo(d,g)(1,3,6)dioxazocin-12-yl)-1-prop yl)-3-piperidinecarboxylic acid, for example; treating neurogenic pain (in which c-fibers play a role) or inflammation such as migraine or diabetic neuropathy
10/26/1999US5972917 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders
10/26/1999US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999US5972897 Acylated enol derivatives as prodrugs of elastase inhibitors
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972698 Tryptase is expressed virtually exclusively by mast cells.
10/26/1999US5972688 HTm4 methods of treatment and assays, agonists and antagonists
10/26/1999US5972652 Polynucleotides encoding secreted proteins
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999CA2177576C Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
10/26/1999CA2132993C Physiologically active substance
10/21/1999WO1999053055A2 Therapeutic agent for ngf
10/21/1999WO1999052935A1 Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999WO1999052927A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999WO1999052903A1 Prodrugs of benzofuranylmethyl carbamate nk1 antagonists
10/21/1999WO1999052898A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
10/21/1999WO1999052896A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999WO1999052889A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
10/21/1999WO1999052876A1 Azacycloalkane derivatives, preparation and therapeutic application
10/21/1999WO1999052868A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999WO1999052862A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
10/21/1999WO1999052555A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999WO1999052554A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
10/21/1999WO1999052528A1 Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
10/21/1999WO1999052525A1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
10/21/1999WO1999052524A1 Use of cannabinoids as anti-inflammatory agents
10/21/1999WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999WO1999052508A1 Method for the treatment of asthma
10/21/1999WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999WO1999040061A3 Novel dihydroxyhexanoic acid derivatives
10/21/1999WO1999030157A9 Neuropilins in methods for diagnosis and prognosis of cancer
10/21/1999DE19916896A1 Particles for chelating metal ions, useful in cosmetic, pharmaceutical and food products and products for treating liquids, especially water
10/21/1999DE19827633A1 Production of N-methyl-N-(1-phenyl-2-(3-hydroxypyrrolidino)ethyl)-2,2-diphenylacetamide enantiomers, e.g. with antiinflammatory, analgesic and diuretic activity
10/21/1999DE19817461A1 New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
10/21/1999CA2328878A1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
10/21/1999CA2328344A1 Method for the treatment of asthma
10/21/1999CA2328211A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999CA2328075A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999CA2327431A1 Pharmaceutical composition
10/21/1999CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999CA2325629A1 Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999CA2325559A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999CA2325332A1 Therapeutic agent for ngf
10/21/1999CA2293605A1 Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
10/20/1999EP0950661A1 Substituted tricyclics useful in sPLA2 induced diseases
10/20/1999EP0950657A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
10/20/1999EP0950656A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
10/20/1999EP0950408A1 Oily patches for external use containing diclofenac sodium
10/20/1999EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999EP0950065A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
10/20/1999EP0950060A1 Antisense inhibition of human adhesion molecules
10/20/1999EP0950058A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
10/20/1999EP0950057A1 3-pyridyl enantiomers and their use as analgesics
10/20/1999EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999EP0949931A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
10/20/1999EP0949917A1 Substances and their uses
10/20/1999EP0949902A2 Cosmetic preparation with a peptide addition
10/20/1999EP0949865A1 The use of cd4-binding small molecules to inhibit immune responses
10/20/1999EP0832078B1 N-hydroxyureas as antiinflammatory agents
10/20/1999EP0788476B1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
1 ... 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 ... 1272